Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells
Courtney L. Jones(University of Colorado Denver), Craig T. Jordan(University of Colorado Anschutz Medical Campus), Julie A. Reisz(University of Colorado Anschutz Medical Campus), Fabia Gamboni(Ospedale Policlinico San Martino), Mohammad Minhajuddin(University of Colorado Denver), Anagha Inguva Sheth(University of Colorado Anschutz Medical Campus), Daniel A. Pollyea(University of Colorado Denver), Haobin Ye(Fudan University), James DeGregori(University of Colorado Cancer Center), Annika Gustafson(University of Colorado Denver), Sarah Gehrke(University of Colorado Denver), Maria L. Amaya(University of Colorado Denver), Rachel Culp‐Hill(University of Colorado Denver), Travis Nemkov(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Brett M. Stevens(University of Colorado Anschutz Medical Campus), Anna Krug(University of Colorado Anschutz Medical Campus), Clayton A. Smith(University of Colorado Anschutz Medical Campus), Michael W. Becker(Helios Hospital Berlin-Buch), Shanshan Pei(University of Colorado Anschutz Medical Campus), Diana Abbott(University of Colorado Anschutz Medical Campus), Amanda Winters(University of Colorado Denver)
Cited by 228
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
|Blood|2005|675
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655